225 related articles for article (PubMed ID: 17305539)
1. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer.
Calzado MA; Bacher S; Schmitz ML
Curr Med Chem; 2007; 14(3):367-76. PubMed ID: 17305539
[TBL] [Abstract][Full Text] [Related]
2. NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and Perspectives.
Freitas RHCN; Fraga CAM
Curr Drug Targets; 2018; 19(16):1933-1942. PubMed ID: 29468963
[TBL] [Abstract][Full Text] [Related]
3. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.
Edwards MR; Bartlett NW; Clarke D; Birrell M; Belvisi M; Johnston SL
Pharmacol Ther; 2009 Jan; 121(1):1-13. PubMed ID: 18950657
[TBL] [Abstract][Full Text] [Related]
4. Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ.
Umezawa K
Biomed Pharmacother; 2011 Jul; 65(4):252-9. PubMed ID: 21723080
[TBL] [Abstract][Full Text] [Related]
5. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors.
Pande V; Ramos MJ
Curr Med Chem; 2005; 12(3):357-74. PubMed ID: 15723624
[TBL] [Abstract][Full Text] [Related]
7. Nuclear transcription factor-kappaB as a target for cancer drug development.
Garg A; Aggarwal BB
Leukemia; 2002 Jun; 16(6):1053-68. PubMed ID: 12040437
[TBL] [Abstract][Full Text] [Related]
8. Targeting IKKβ for the treatment of rheumatoid arthritis.
Bamborough P; Morse MA; Ray KP
Drug News Perspect; 2010 Oct; 23(8):483-90. PubMed ID: 21031164
[TBL] [Abstract][Full Text] [Related]
9. Direct Rel/NF-κB inhibitors: structural basis for mechanism of action.
Ouk S; Liou ML; Liou HC
Future Med Chem; 2009 Dec; 1(9):1683-707. PubMed ID: 21425986
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.
Yamamoto Y; Gaynor RB
J Clin Invest; 2001 Jan; 107(2):135-42. PubMed ID: 11160126
[No Abstract] [Full Text] [Related]
11. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
Wong ET; Tergaonkar V
Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
[TBL] [Abstract][Full Text] [Related]
12. [NF-kappa B as a therapeutic drug target].
Hishikawa K; Nakaki T
Nihon Yakurigaku Zasshi; 2001 Sep; 118(3):197-202. PubMed ID: 11577460
[TBL] [Abstract][Full Text] [Related]
13. Small Molecule NF-κB Pathway Inhibitors in Clinic.
Ramadass V; Vaiyapuri T; Tergaonkar V
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708302
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibition: a new anti-inflammatory strategy.
Elliott PJ; Zollner TM; Boehncke WH
J Mol Med (Berl); 2003 Apr; 81(4):235-45. PubMed ID: 12700891
[TBL] [Abstract][Full Text] [Related]
15. Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer.
Nguyen DP; Li J; Yadav SS; Tewari AK
BJU Int; 2014 Aug; 114(2):168-76. PubMed ID: 24215139
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB in cancer--a friend turned foe.
Ravi R; Bedi A
Drug Resist Updat; 2004 Feb; 7(1):53-67. PubMed ID: 15072771
[TBL] [Abstract][Full Text] [Related]
17. A novel inhibitor of I-kappaB kinase beta ameliorates experimental arthritis through downregulation of proinflammatory cytokines in arthritic joints.
Tanaka S; Toki T; Yokoyama M; Shimizu H; Yamasaki T; Yoneda Y; Muro F; Yasukochi T; Iimura S; Morishita K
Biol Pharm Bull; 2014; 37(1):87-95. PubMed ID: 24389485
[TBL] [Abstract][Full Text] [Related]
18. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
19. Targeting IKK and NF-κB for Therapy.
Durand JK; Baldwin AS
Adv Protein Chem Struct Biol; 2017; 107():77-115. PubMed ID: 28215229
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease.
Roshak AK; Callahan JF; Blake SM
Curr Opin Pharmacol; 2002 Jun; 2(3):316-21. PubMed ID: 12020477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
